ProfileGDS4718 / 1557523_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 9% 11% 6% 8% 4% 10% 8% 8% 12% 10% 8% 11% 17% 14% 13% 8% 7% 10% 21% 26% 10% 9% 4% 5% 11% 12% 9% 21% 5% 10% 12% 10% 10% 9% 12% 11% 23% 8% 11% 9% 4% 17% 27% 12% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.757649
GSM549102patient 115, normal, homogenized [OPG study]3.822511
GSM549104patient 119, normal, homogenized [OPG study]3.582426
GSM549108patient 138, normal, homogenized [OPG study]3.741748
GSM549119patient 077, normal, homogenized [OPG study]3.549984
GSM549133patient 032, cancer, homogenized [OPG study]3.7239410
GSM549139patient 042, cancer, homogenized [OPG study]3.695628
GSM549099patient 107, normal, homogenized [OPG study]3.702458
GSM549109patient 139, normal, homogenized [OPG study]3.8849112
GSM549110patient 046, normal, homogenized [OPG study]3.7815310
GSM549114patient 063, normal, homogenized [OPG study]3.690758
GSM549122patient 082, normal, homogenized [OPG study]3.8343511
GSM549134patient 033, cancer, homogenized [OPG study]4.0188717
GSM549136patient 036, cancer, homogenized [OPG study]3.868214
GSM549140patient 044, cancer, homogenized [OPG study]3.8511613
GSM549111patient 047, normal, homogenized [OPG study]3.679098
GSM549113patient 057, normal, homogenized [OPG study]3.635427
GSM549132patient 031, cancer, homogenized [OPG study]3.7579910
GSM549137patient 038, cancer, homogenized [OPG study]4.1889821
GSM549142patient 047, cancer, homogenized [OPG study]4.5032226
GSM549100patient 110, normal, homogenized [OPG study]3.7878310
GSM549107patient 135, normal, homogenized [OPG study]3.731149
GSM549115patient 068, normal, homogenized [OPG study]3.546624
GSM549116patient 072, normal, homogenized [OPG study]3.567025
GSM549120patient 078, normal, homogenized [OPG study]3.8255511
GSM549131patient 030, cancer, homogenized [OPG study]3.7998812
GSM549118patient 074, normal, homogenized [OPG study]3.759229
GSM549129patient 027, cancer, homogenized [OPG study]4.1819221
GSM549123patient 088, normal, homogenized [OPG study]3.622615
GSM549124patient 006, cancer, homogenized [OPG study]3.8092110
GSM549126patient 015, cancer, homogenized [OPG study]3.8430912
GSM549128patient 025, cancer, homogenized [OPG study]3.7461310
GSM549103patient 117, normal, homogenized [OPG study]3.8228610
GSM549117patient 073, normal, homogenized [OPG study]3.759659
GSM549138patient 041, cancer, homogenized [OPG study]3.827412
GSM549141patient 045, cancer, homogenized [OPG study]3.7602611
GSM549130patient 028, cancer, homogenized [OPG study]4.285623
GSM549101patient 111, normal, homogenized [OPG study]3.70538
GSM549105patient 128, normal, homogenized [OPG study]3.8387911
GSM549106patient 134, normal, homogenized [OPG study]3.71949
GSM549112patient 048, normal, homogenized [OPG study]3.540154
GSM549125patient 011, cancer, homogenized [OPG study]4.0288617
GSM549127patient 024, cancer, homogenized [OPG study]4.4168627
GSM549135patient 035, cancer, homogenized [OPG study]3.8138112